drugset / Trial / NCT01203592
Efficacy of Albuterol in the Treatment of Congenital Myasthenic Syndromes
NaSingle-groupOpen-labelTreatment
Summary
The study tests the notion that patients suffering from certain types of congenital myasthenic syndromes are benefitted by the use of Albuterol at doses used in clinical practice.
Timeline
- Start
- 2010-09
- Primary completion
- 2013-08
- Completion
- 2013-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Salbutamol | Unknown | 0.1 mg/kg | Oral |
| Subject | Salbutamol | Unknown | 2 mg | Oral |
| Subject | Salbutamol | Unknown | 4 mg | Oral |